Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Boundless Bio
Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
May 13, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
May 06, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
April 11, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024
April 08, 2024
From
Boundless Bio
Via
Business Wire
Tickers
BOLD
Boundless Bio Announces Pricing of Initial Public Offering
March 27, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Multiple Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2024
March 05, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio Presents Preclinical Data on the Discovery of its Second ecDNA-Directed Therapeutic Candidate, BBI-825, at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Upcoming Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 04, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints New Board Members and Establishes Clinical Advisory Board
October 02, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate VERZENIO® (abemaciclib) in Combination with BBI-355 in Patients with CDK4 or CDK6 Amplified Solid Tumors
September 19, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Clinical Trial Collaboration and Supply Agreement with Taiho Oncology to Evaluate LYTGOBI® (futibatinib) in Combination with BBI-355 in Patients with FGFR Amplified Solid Tumors
September 18, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Jami Rubin as Chief Financial Officer
July 31, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the 2023 Jefferies Healthcare Conference
June 01, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-355 in Patients with Solid Tumors Harboring Oncogene Amplification
May 09, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Presents Data on the Novel Discovery of CHK1 as an Extrachromosomal DNA (ecDNA) Essential Target in Oncogene Amplified Cancers at the American Association for Cancer Research Annual Meeting 2023
April 17, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the Stifel 2023 Virtual Targeted Oncology Days
April 11, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 04, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces Upcoming Presentation at the American Association for Cancer Research Annual Meeting 2023
March 15, 2023
From
Boundless Bio
Via
Business Wire
Boundless Bio to Participate at Two Upcoming Investor Conferences
November 15, 2022
From
Boundless Bio
Via
Business Wire
Team Led by Boundless Bio Scientific Founders Receives $25M Award to Better Understand Extrachromosomal DNA (ecDNA) Through Cancer Grand Challenges
June 16, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the 2022 Jefferies Healthcare Conference
June 06, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Sara Weymer as Vice President, Clinical Operations
June 03, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Presents Data on the Novel Discovery of the Association Between Extrachromosomal DNA (ecDNA) and Replication Stress at the American Association for Cancer Research Annual Meeting 2022
April 08, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Klaus Wagner, M.D., Ph.D., as Chief Medical Officer
February 22, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Amy Berkley, Ph.D., as Vice President, Program Team Leadership and Strategic Alliances
February 07, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the Guggenheim Oncology Conference
February 02, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Peter Krein, Ph.D., as Vice President, Precision Medicine
January 17, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio Appoints Jennifer Lew to its Board of Directors
January 05, 2022
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
Boundless Bio
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.